However, as has been shown in multiple studies, including a meta-analysis by Swardfager et al. (2020), levels of IL-6 seem to be elevated in neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases, revealing an inflammatory response in these conditions [65]. Here, IL6 is linked to neurodegenerative disease.